

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 6.29636381 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 5.39692463 |
| 3 | regulation of mitochondrial translation (GO:0070129) | 4.41867858 |
| 4 | viral transcription (GO:0019083) | 4.16594136 |
| 5 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.15297080 |
| 6 | proteasome assembly (GO:0043248) | 4.07802684 |
| 7 | translational termination (GO:0006415) | 4.03864934 |
| 8 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.01134791 |
| 9 | cotranslational protein targeting to membrane (GO:0006613) | 3.92072960 |
| 10 | nucleotide salvage (GO:0043173) | 3.92017950 |
| 11 | protein targeting to ER (GO:0045047) | 3.89772514 |
| 12 | ribosomal small subunit biogenesis (GO:0042274) | 3.85754425 |
| 13 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.83118940 |
| 14 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.77178197 |
| 15 | proline biosynthetic process (GO:0006561) | 3.76595728 |
| 16 | protein localization to endoplasmic reticulum (GO:0070972) | 3.75202939 |
| 17 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.74980941 |
| 18 | translational elongation (GO:0006414) | 3.67578834 |
| 19 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.65931631 |
| 20 | DNA strand elongation (GO:0022616) | 3.62415485 |
| 21 | base-excision repair, AP site formation (GO:0006285) | 3.58684220 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.57888587 |
| 23 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.57023778 |
| 24 | protein targeting to mitochondrion (GO:0006626) | 3.54862467 |
| 25 | pyrimidine nucleoside salvage (GO:0043097) | 3.50694013 |
| 26 | pyrimidine-containing compound salvage (GO:0008655) | 3.50694013 |
| 27 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.50198682 |
| 28 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.48957054 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.46254628 |
| 30 | GDP-mannose metabolic process (GO:0019673) | 3.43419256 |
| 31 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.41628766 |
| 32 | formation of translation preinitiation complex (GO:0001731) | 3.38970389 |
| 33 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.38188061 |
| 34 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.38188061 |
| 35 | folic acid metabolic process (GO:0046655) | 3.37414828 |
| 36 | oxidative phosphorylation (GO:0006119) | 3.36509347 |
| 37 | translational initiation (GO:0006413) | 3.33584187 |
| 38 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.33016196 |
| 39 | negative regulation of ligase activity (GO:0051352) | 3.33016196 |
| 40 | nucleoside salvage (GO:0043174) | 3.31273663 |
| 41 | telomere maintenance via recombination (GO:0000722) | 3.29412349 |
| 42 | maturation of SSU-rRNA (GO:0030490) | 3.28302951 |
| 43 | negative regulation of B cell apoptotic process (GO:0002903) | 3.27705429 |
| 44 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.27126939 |
| 45 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.26840721 |
| 46 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.25728894 |
| 47 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.25598332 |
| 48 | establishment of protein localization to mitochondrion (GO:0072655) | 3.25560152 |
| 49 | DNA replication initiation (GO:0006270) | 3.23976533 |
| 50 | cellular protein complex disassembly (GO:0043624) | 3.21932384 |
| 51 | viral life cycle (GO:0019058) | 3.21128138 |
| 52 | translation (GO:0006412) | 3.20322071 |
| 53 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.19625093 |
| 54 | purine nucleotide salvage (GO:0032261) | 3.19144524 |
| 55 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.19098795 |
| 56 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.19098795 |
| 57 | nucleobase biosynthetic process (GO:0046112) | 3.18337769 |
| 58 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.17868542 |
| 59 | termination of RNA polymerase III transcription (GO:0006386) | 3.16858868 |
| 60 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.16858868 |
| 61 | deoxyribose phosphate metabolic process (GO:0019692) | 3.16666770 |
| 62 | rRNA modification (GO:0000154) | 3.15537874 |
| 63 | protein deneddylation (GO:0000338) | 3.15442554 |
| 64 | DNA unwinding involved in DNA replication (GO:0006268) | 3.15170532 |
| 65 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.14435884 |
| 66 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.14435884 |
| 67 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.14435884 |
| 68 | pentose metabolic process (GO:0019321) | 3.13675933 |
| 69 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.11759404 |
| 70 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.10631505 |
| 71 | heme biosynthetic process (GO:0006783) | 3.10522539 |
| 72 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.09287827 |
| 73 | signal peptide processing (GO:0006465) | 3.08538129 |
| 74 | metallo-sulfur cluster assembly (GO:0031163) | 3.08131962 |
| 75 | iron-sulfur cluster assembly (GO:0016226) | 3.08131962 |
| 76 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.07200896 |
| 77 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.06358084 |
| 78 | DNA replication checkpoint (GO:0000076) | 3.04835842 |
| 79 | pseudouridine synthesis (GO:0001522) | 3.04695675 |
| 80 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.03931628 |
| 81 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.02755000 |
| 82 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.02755000 |
| 83 | mitochondrial fusion (GO:0008053) | 3.02552665 |
| 84 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.00740465 |
| 85 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 3.00571105 |
| 86 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.00418073 |
| 87 | protein maturation by protein folding (GO:0022417) | 2.99675467 |
| 88 | regulation of translational fidelity (GO:0006450) | 2.98838355 |
| 89 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.98252983 |
| 90 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.96349184 |
| 91 | purine nucleobase biosynthetic process (GO:0009113) | 2.96235930 |
| 92 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.95687098 |
| 93 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.95457978 |
| 94 | protein localization to mitochondrion (GO:0070585) | 2.95365737 |
| 95 | purine-containing compound salvage (GO:0043101) | 2.95046449 |
| 96 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.94543972 |
| 97 | tRNA modification (GO:0006400) | 2.94312330 |
| 98 | protein retention in ER lumen (GO:0006621) | 2.93486471 |
| 99 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.93350911 |
| 100 | peptidyl-histidine modification (GO:0018202) | 2.87804987 |
| 101 | ribosomal large subunit biogenesis (GO:0042273) | 2.87752783 |
| 102 | deoxyribonucleotide metabolic process (GO:0009262) | 2.87272694 |
| 103 | tRNA methylation (GO:0030488) | 2.87130460 |
| 104 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.87125944 |
| 105 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.85621644 |
| 106 | base-excision repair (GO:0006284) | 2.85057452 |
| 107 | cullin deneddylation (GO:0010388) | 2.83481116 |
| 108 | UTP biosynthetic process (GO:0006228) | 2.83300842 |
| 109 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.82929018 |
| 110 | mitotic nuclear envelope reassembly (GO:0007084) | 2.82290538 |
| 111 | nuclear envelope reassembly (GO:0031468) | 2.82290538 |
| 112 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.82008459 |
| 113 | NADH dehydrogenase complex assembly (GO:0010257) | 2.82008459 |
| 114 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.82008459 |
| 115 | respiratory electron transport chain (GO:0022904) | 2.81956617 |
| 116 | neutrophil activation involved in immune response (GO:0002283) | 2.81836896 |
| 117 | ribosome biogenesis (GO:0042254) | 2.81695596 |
| 118 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.81673757 |
| 119 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.81436942 |
| 120 | cellular component biogenesis (GO:0044085) | 2.81136651 |
| 121 | protein insertion into membrane (GO:0051205) | 2.80698032 |
| 122 | rRNA processing (GO:0006364) | 2.79465893 |
| 123 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.79362886 |
| 124 | chaperone-mediated protein transport (GO:0072321) | 2.78627274 |
| 125 | deoxyribonucleotide catabolic process (GO:0009264) | 2.78387295 |
| 126 | response to interferon-beta (GO:0035456) | 2.78295311 |
| 127 | histone arginine methylation (GO:0034969) | 2.78279148 |
| 128 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.77990376 |
| 129 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.77306170 |
| 130 | heme metabolic process (GO:0042168) | 2.77196702 |
| 131 | protein complex disassembly (GO:0043241) | 2.76885979 |
| 132 | positive regulation of ligase activity (GO:0051351) | 2.75225962 |
| 133 | peptidyl-arginine N-methylation (GO:0035246) | 2.74702873 |
| 134 | peptidyl-arginine methylation (GO:0018216) | 2.74702873 |
| 135 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.74534659 |
| 136 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.74428319 |
| 137 | 7-methylguanosine mRNA capping (GO:0006370) | 2.73562630 |
| 138 | UV protection (GO:0009650) | 2.73211000 |
| 139 | electron transport chain (GO:0022900) | 2.72738043 |
| 140 | protein complex biogenesis (GO:0070271) | 2.71624172 |
| 141 | mitotic recombination (GO:0006312) | 2.71443395 |
| 142 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.69681711 |
| 143 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.69221648 |
| 144 | L-methionine salvage (GO:0071267) | 2.68596588 |
| 145 | L-methionine biosynthetic process (GO:0071265) | 2.68596588 |
| 146 | amino acid salvage (GO:0043102) | 2.68596588 |
| 147 | macromolecular complex disassembly (GO:0032984) | 2.67459247 |
| 148 | 7-methylguanosine RNA capping (GO:0009452) | 2.64508336 |
| 149 | RNA capping (GO:0036260) | 2.64508336 |
| 150 | deoxyribose phosphate catabolic process (GO:0046386) | 2.64295425 |
| 151 | telomere maintenance via telomere lengthening (GO:0010833) | 2.64226735 |
| 152 | rRNA metabolic process (GO:0016072) | 2.63937594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.36613326 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.96635472 |
| 3 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.36895270 |
| 4 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.34467460 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.32171638 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.31741439 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.10483652 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.92855058 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.86924837 |
| 10 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.74658503 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.63734556 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.61595055 |
| 13 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.50870685 |
| 14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.43655343 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.30468622 |
| 16 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27828607 |
| 17 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.25338541 |
| 18 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.24737694 |
| 19 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.17706671 |
| 20 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.16999792 |
| 21 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.10829203 |
| 22 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.09603492 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.06328590 |
| 24 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03528282 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.01919699 |
| 26 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.00061120 |
| 27 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.99790021 |
| 28 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.99651069 |
| 29 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.96649031 |
| 30 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.94582022 |
| 31 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.94107996 |
| 32 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.92730949 |
| 33 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.89208787 |
| 34 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.86778178 |
| 35 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.85371577 |
| 36 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.82449907 |
| 37 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.82297195 |
| 38 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.81074887 |
| 39 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.80222807 |
| 40 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.76413858 |
| 41 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.75091869 |
| 42 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.74160887 |
| 43 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.73260679 |
| 44 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.71482727 |
| 45 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.68111328 |
| 46 | P68_20966046_ChIP-Seq_HELA_Human | 1.67735069 |
| 47 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67008846 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65446698 |
| 49 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.63672383 |
| 50 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.63463057 |
| 51 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.60799854 |
| 52 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.60617585 |
| 53 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56044532 |
| 54 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.53788778 |
| 55 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.51207285 |
| 56 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.49802416 |
| 57 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.46993413 |
| 58 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.46915090 |
| 59 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.43703618 |
| 60 | MYC_22102868_ChIP-Seq_BL_Human | 1.43426142 |
| 61 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.42275935 |
| 62 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.39240328 |
| 63 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38992507 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.38608966 |
| 65 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.37901868 |
| 66 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.37672144 |
| 67 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.35913861 |
| 68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.34714996 |
| 69 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.34487592 |
| 70 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.33869917 |
| 71 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.32699369 |
| 72 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.32517504 |
| 73 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.32263431 |
| 74 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.30847430 |
| 75 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.30038161 |
| 76 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.28809878 |
| 77 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28073129 |
| 78 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.28028158 |
| 79 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26682008 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25589879 |
| 81 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.24784178 |
| 82 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.23150482 |
| 83 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.20956556 |
| 84 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.20346538 |
| 85 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.20199621 |
| 86 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.19407658 |
| 87 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.19304230 |
| 88 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.16380288 |
| 89 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.16255176 |
| 90 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.16018758 |
| 91 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.14614989 |
| 92 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.12418258 |
| 93 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.12055241 |
| 94 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.11704319 |
| 95 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.10051040 |
| 96 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.09510425 |
| 97 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.08952050 |
| 98 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.08903010 |
| 99 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.08799015 |
| 100 | UTX_26944678_Chip-Seq_JUKART_Human | 1.08791295 |
| 101 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08595501 |
| 102 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08570508 |
| 103 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.08168178 |
| 104 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.07622655 |
| 105 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.07501540 |
| 106 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.07338310 |
| 107 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07308706 |
| 108 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.06806636 |
| 109 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.06589815 |
| 110 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.06316164 |
| 111 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.06171211 |
| 112 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.05847234 |
| 113 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.05606291 |
| 114 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.04273412 |
| 115 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.04070817 |
| 116 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.03617739 |
| 117 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.02727730 |
| 118 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00452262 |
| 119 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99102388 |
| 120 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.98772279 |
| 121 | MAF_26560356_Chip-Seq_TH2_Human | 0.98517965 |
| 122 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.98355927 |
| 123 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.97853553 |
| 124 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.97251695 |
| 125 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.96804323 |
| 126 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96459214 |
| 127 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.95155951 |
| 128 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.94755710 |
| 129 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94404885 |
| 130 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.94386142 |
| 131 | MAF_26560356_Chip-Seq_TH1_Human | 0.94071242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.09244309 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.07715178 |
| 3 | MP0002396_abnormal_hematopoietic_system | 2.79434871 |
| 4 | MP0000685_abnormal_immune_system | 2.67023107 |
| 5 | MP0003656_abnormal_erythrocyte_physiolo | 2.63636259 |
| 6 | MP0009785_altered_susceptibility_to | 2.47904488 |
| 7 | MP0005671_abnormal_response_to | 2.46324074 |
| 8 | MP0003186_abnormal_redox_activity | 2.42897382 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.39601084 |
| 10 | MP0009333_abnormal_splenocyte_physiolog | 2.36594555 |
| 11 | MP0004957_abnormal_blastocyst_morpholog | 2.29352859 |
| 12 | MP0010094_abnormal_chromosome_stability | 2.25892125 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.25763142 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.19645343 |
| 15 | MP0008007_abnormal_cellular_replicative | 2.13550338 |
| 16 | MP0003436_decreased_susceptibility_to | 2.11668121 |
| 17 | MP0003077_abnormal_cell_cycle | 2.09830221 |
| 18 | MP0001545_abnormal_hematopoietic_system | 2.09199988 |
| 19 | MP0005397_hematopoietic_system_phenotyp | 2.09199988 |
| 20 | MP0006054_spinal_hemorrhage | 2.05110682 |
| 21 | MP0005025_abnormal_response_to | 1.99696596 |
| 22 | MP0005000_abnormal_immune_tolerance | 1.99360633 |
| 23 | MP0006036_abnormal_mitochondrial_physio | 1.97821908 |
| 24 | MP0005083_abnormal_biliary_tract | 1.97578989 |
| 25 | MP0009840_abnormal_foam_cell | 1.97338216 |
| 26 | MP0002398_abnormal_bone_marrow | 1.96043163 |
| 27 | MP0003724_increased_susceptibility_to | 1.95413494 |
| 28 | MP0008058_abnormal_DNA_repair | 1.93695749 |
| 29 | MP0002249_abnormal_larynx_morphology | 1.89464281 |
| 30 | MP0002420_abnormal_adaptive_immunity | 1.88070361 |
| 31 | MP0001819_abnormal_immune_cell | 1.86224734 |
| 32 | MP0002452_abnormal_antigen_presenting | 1.84293882 |
| 33 | MP0001661_extended_life_span | 1.84267755 |
| 34 | MP0003111_abnormal_nucleus_morphology | 1.82607805 |
| 35 | MP0002723_abnormal_immune_serum | 1.82574355 |
| 36 | MP0001800_abnormal_humoral_immune | 1.81228036 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.80764132 |
| 38 | MP0002419_abnormal_innate_immunity | 1.78271944 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.74660326 |
| 40 | MP0000490_abnormal_crypts_of | 1.70569310 |
| 41 | MP0009278_abnormal_bone_marrow | 1.70110363 |
| 42 | MP0000716_abnormal_immune_system | 1.69411895 |
| 43 | MP0000681_abnormal_thyroid_gland | 1.68841960 |
| 44 | MP0002132_abnormal_respiratory_system | 1.67203092 |
| 45 | MP0002429_abnormal_blood_cell | 1.67183914 |
| 46 | MP0002722_abnormal_immune_system | 1.65575655 |
| 47 | MP0004233_abnormal_muscle_weight | 1.65430347 |
| 48 | MP0004808_abnormal_hematopoietic_stem | 1.64286372 |
| 49 | MP0005410_abnormal_fertilization | 1.62251025 |
| 50 | MP0005451_abnormal_body_composition | 1.61915468 |
| 51 | MP0009379_abnormal_foot_pigmentation | 1.60686336 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.60396552 |
| 53 | MP0001853_heart_inflammation | 1.59617247 |
| 54 | MP0001764_abnormal_homeostasis | 1.56512020 |
| 55 | MP0004147_increased_porphyrin_level | 1.54728316 |
| 56 | MP0005058_abnormal_lysosome_morphology | 1.44184818 |
| 57 | MP0005075_abnormal_melanosome_morpholog | 1.42570729 |
| 58 | MP0002405_respiratory_system_inflammati | 1.42537179 |
| 59 | MP0005387_immune_system_phenotype | 1.41318521 |
| 60 | MP0001790_abnormal_immune_system | 1.41318521 |
| 61 | MP0006082_CNS_inflammation | 1.38322045 |
| 62 | MP0002877_abnormal_melanocyte_morpholog | 1.36602990 |
| 63 | MP0001348_abnormal_lacrimal_gland | 1.36475886 |
| 64 | MP0000750_abnormal_muscle_regeneration | 1.33637216 |
| 65 | MP0001845_abnormal_inflammatory_respons | 1.32888195 |
| 66 | MP0008469_abnormal_protein_level | 1.32723474 |
| 67 | MP0008995_early_reproductive_senescence | 1.31305504 |
| 68 | MP0008932_abnormal_embryonic_tissue | 1.29895417 |
| 69 | MP0005330_cardiomyopathy | 1.28988831 |
| 70 | MP0001986_abnormal_taste_sensitivity | 1.26591664 |
| 71 | MP0000703_abnormal_thymus_morphology | 1.26463872 |
| 72 | MP0005171_absent_coat_pigmentation | 1.26015309 |
| 73 | MP0005501_abnormal_skin_physiology | 1.23617324 |
| 74 | MP0004185_abnormal_adipocyte_glucose | 1.22756941 |
| 75 | MP0000858_altered_metastatic_potential | 1.22713092 |
| 76 | MP0002019_abnormal_tumor_incidence | 1.22382297 |
| 77 | MP0000343_altered_response_to | 1.21065679 |
| 78 | MP0000358_abnormal_cell_content/ | 1.20685267 |
| 79 | MP0005310_abnormal_salivary_gland | 1.19336121 |
| 80 | MP0003786_premature_aging | 1.18328513 |
| 81 | MP0000003_abnormal_adipose_tissue | 1.17323295 |
| 82 | MP0000015_abnormal_ear_pigmentation | 1.16593386 |
| 83 | MP0001730_embryonic_growth_arrest | 1.14926800 |
| 84 | MP0004858_abnormal_nervous_system | 1.14790099 |
| 85 | MP0010030_abnormal_orbit_morphology | 1.14481720 |
| 86 | MP0000313_abnormal_cell_death | 1.13072831 |
| 87 | MP0002234_abnormal_pharynx_morphology | 1.11502761 |
| 88 | MP0008877_abnormal_DNA_methylation | 1.10573376 |
| 89 | MP0003191_abnormal_cellular_cholesterol | 1.10089592 |
| 90 | MP0001533_abnormal_skeleton_physiology | 1.09829617 |
| 91 | MP0000747_muscle_weakness | 1.05648093 |
| 92 | MP0003866_abnormal_defecation | 1.01567731 |
| 93 | MP0008057_abnormal_DNA_replication | 1.01376861 |
| 94 | MP0009697_abnormal_copulation | 1.00061155 |
| 95 | MP0010155_abnormal_intestine_physiology | 0.99597004 |
| 96 | MP0006035_abnormal_mitochondrial_morpho | 0.99272734 |
| 97 | MP0005636_abnormal_mineral_homeostasis | 0.97825157 |
| 98 | MP0002080_prenatal_lethality | 0.97674879 |
| 99 | MP0001346_abnormal_lacrimal_gland | 0.97119078 |
| 100 | MP0001929_abnormal_gametogenesis | 0.96408746 |
| 101 | MP0002160_abnormal_reproductive_system | 0.96365758 |
| 102 | MP0002210_abnormal_sex_determination | 0.96001254 |
| 103 | MP0005174_abnormal_tail_pigmentation | 0.95656699 |
| 104 | MP0002163_abnormal_gland_morphology | 0.94093938 |
| 105 | MP0004510_myositis | 0.91855486 |
| 106 | MP0001188_hyperpigmentation | 0.87537510 |
| 107 | MP0010307_abnormal_tumor_latency | 0.85349658 |
| 108 | MP0001529_abnormal_vocalization | 0.84628977 |
| 109 | MP0000759_abnormal_skeletal_muscle | 0.84389039 |
| 110 | MP0005645_abnormal_hypothalamus_physiol | 0.83546870 |
| 111 | MP0000751_myopathy | 0.82975155 |
| 112 | MP0009643_abnormal_urine_homeostasis | 0.81670864 |
| 113 | MP0008260_abnormal_autophagy | 0.81516948 |
| 114 | MP0001697_abnormal_embryo_size | 0.79941568 |
| 115 | MP0008875_abnormal_xenobiotic_pharmacok | 0.78055852 |
| 116 | MP0005319_abnormal_enzyme/_coenzyme | 0.77788578 |
| 117 | MP0003172_abnormal_lysosome_physiology | 0.77507697 |
| 118 | MP0003718_maternal_effect | 0.77381754 |
| 119 | MP0005332_abnormal_amino_acid | 0.76827140 |
| 120 | MP0000678_abnormal_parathyroid_gland | 0.75265434 |
| 121 | MP0002933_joint_inflammation | 0.74261668 |
| 122 | MP0000350_abnormal_cell_proliferation | 0.74216774 |
| 123 | MP0001542_abnormal_bone_strength | 0.72938771 |
| 124 | MP0001145_abnormal_male_reproductive | 0.72892084 |
| 125 | MP0005423_abnormal_somatic_nervous | 0.72711324 |
| 126 | MP0000598_abnormal_liver_morphology | 0.72681215 |
| 127 | MP0001727_abnormal_embryo_implantation | 0.71912912 |
| 128 | MP0000372_irregular_coat_pigmentation | 0.71688302 |
| 129 | MP0009763_increased_sensitivity_to | 0.71643254 |
| 130 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71634579 |
| 131 | MP0005384_cellular_phenotype | 0.69875808 |
| 132 | MP0001873_stomach_inflammation | 0.69403383 |
| 133 | MP0004947_skin_inflammation | 0.69252805 |
| 134 | MP0002822_catalepsy | 0.68711989 |
| 135 | MP0005375_adipose_tissue_phenotype | 0.68708385 |
| 136 | MP0001905_abnormal_dopamine_level | 0.67511349 |
| 137 | MP0002970_abnormal_white_adipose | 0.66913734 |
| 138 | MP0001881_abnormal_mammary_gland | 0.66241561 |
| 139 | MP0004381_abnormal_hair_follicle | 0.66147542 |
| 140 | MP0009931_abnormal_skin_appearance | 0.65682483 |
| 141 | MP0002269_muscular_atrophy | 0.64552489 |
| 142 | MP0005623_abnormal_meninges_morphology | 0.64435266 |
| 143 | MP0003453_abnormal_keratinocyte_physiol | 0.63839752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal number of erythroid precursors (HP:0012131) | 4.26577657 |
| 2 | Thrombocytosis (HP:0001894) | 4.20506225 |
| 3 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.14074009 |
| 4 | Truncus arteriosus (HP:0001660) | 4.13746365 |
| 5 | Hyperthyroidism (HP:0000836) | 3.99504626 |
| 6 | Ragged-red muscle fibers (HP:0003200) | 3.91003837 |
| 7 | Microvesicular hepatic steatosis (HP:0001414) | 3.81885738 |
| 8 | Hypertensive crisis (HP:0100735) | 3.68251495 |
| 9 | Aplastic anemia (HP:0001915) | 3.67429988 |
| 10 | Testicular atrophy (HP:0000029) | 3.66864359 |
| 11 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.61005984 |
| 12 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.61005984 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.57200571 |
| 14 | Hepatocellular necrosis (HP:0001404) | 3.55438875 |
| 15 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.51506386 |
| 16 | Progressive muscle weakness (HP:0003323) | 3.45527833 |
| 17 | Petechiae (HP:0000967) | 3.40644731 |
| 18 | Hepatic necrosis (HP:0002605) | 3.33185312 |
| 19 | Microretrognathia (HP:0000308) | 3.21685363 |
| 20 | Type I transferrin isoform profile (HP:0003642) | 3.20492212 |
| 21 | Mitochondrial inheritance (HP:0001427) | 3.11837099 |
| 22 | Reduced antithrombin III activity (HP:0001976) | 3.11183732 |
| 23 | Abnormal gallbladder physiology (HP:0012438) | 3.07173611 |
| 24 | Cholecystitis (HP:0001082) | 3.07173611 |
| 25 | Exertional dyspnea (HP:0002875) | 3.06755327 |
| 26 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.03997179 |
| 27 | 3-Methylglutaconic aciduria (HP:0003535) | 3.01339400 |
| 28 | Seborrheic dermatitis (HP:0001051) | 2.98450711 |
| 29 | Increased hepatocellular lipid droplets (HP:0006565) | 2.97936057 |
| 30 | Poor head control (HP:0002421) | 2.94932486 |
| 31 | Lipid accumulation in hepatocytes (HP:0006561) | 2.94413066 |
| 32 | Myopathic facies (HP:0002058) | 2.91609934 |
| 33 | Acute necrotizing encephalopathy (HP:0006965) | 2.89207537 |
| 34 | Increased CSF lactate (HP:0002490) | 2.87388760 |
| 35 | Birth length less than 3rd percentile (HP:0003561) | 2.86200634 |
| 36 | Abnormal protein glycosylation (HP:0012346) | 2.86185374 |
| 37 | Abnormal glycosylation (HP:0012345) | 2.86185374 |
| 38 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.86185374 |
| 39 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.86185374 |
| 40 | Myositis (HP:0100614) | 2.81072821 |
| 41 | Reticulocytopenia (HP:0001896) | 2.79244250 |
| 42 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.77730288 |
| 43 | Cerebral hypomyelination (HP:0006808) | 2.74384831 |
| 44 | Vertebral compression fractures (HP:0002953) | 2.73074842 |
| 45 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.72889343 |
| 46 | Increased serum lactate (HP:0002151) | 2.71729690 |
| 47 | Macrocytic anemia (HP:0001972) | 2.70084752 |
| 48 | Recurrent abscess formation (HP:0002722) | 2.67760678 |
| 49 | Recurrent bacterial skin infections (HP:0005406) | 2.64506511 |
| 50 | IgM deficiency (HP:0002850) | 2.62807299 |
| 51 | Abnormality of alanine metabolism (HP:0010916) | 2.62426197 |
| 52 | Hyperalaninemia (HP:0003348) | 2.62426197 |
| 53 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.62426197 |
| 54 | Generalized aminoaciduria (HP:0002909) | 2.61121473 |
| 55 | Recurrent bronchitis (HP:0002837) | 2.56950316 |
| 56 | Renal Fanconi syndrome (HP:0001994) | 2.53275576 |
| 57 | Degeneration of anterior horn cells (HP:0002398) | 2.50688950 |
| 58 | Abnormality of the anterior horn cell (HP:0006802) | 2.50688950 |
| 59 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.50666511 |
| 60 | Dicarboxylic aciduria (HP:0003215) | 2.50666511 |
| 61 | Acute encephalopathy (HP:0006846) | 2.49728778 |
| 62 | Increased intramyocellular lipid droplets (HP:0012240) | 2.47110228 |
| 63 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.45075500 |
| 64 | Squamous cell carcinoma (HP:0002860) | 2.44533154 |
| 65 | Abnormality of T cell physiology (HP:0011840) | 2.42361344 |
| 66 | Atelectasis (HP:0100750) | 2.41901247 |
| 67 | Lactic acidosis (HP:0003128) | 2.40714737 |
| 68 | Cholelithiasis (HP:0001081) | 2.40141212 |
| 69 | Hypokinesia (HP:0002375) | 2.36275123 |
| 70 | Increased muscle lipid content (HP:0009058) | 2.35319420 |
| 71 | Esophageal neoplasm (HP:0100751) | 2.32172641 |
| 72 | Neoplasm of head and neck (HP:0012288) | 2.32172641 |
| 73 | Pancytopenia (HP:0001876) | 2.30956001 |
| 74 | Pallor (HP:0000980) | 2.30484584 |
| 75 | Broad distal phalanx of finger (HP:0009836) | 2.28184251 |
| 76 | Abnormality of macrophages (HP:0004311) | 2.27447007 |
| 77 | Stridor (HP:0010307) | 2.26199673 |
| 78 | Neutropenia (HP:0001875) | 2.25800979 |
| 79 | Chronic otitis media (HP:0000389) | 2.25479156 |
| 80 | Poikiloderma (HP:0001029) | 2.25206825 |
| 81 | Abnormality of reticulocytes (HP:0004312) | 2.21032702 |
| 82 | Abnormality of the tricuspid valve (HP:0001702) | 2.20710687 |
| 83 | Purpura (HP:0000979) | 2.17413383 |
| 84 | Opisthotonus (HP:0002179) | 2.17242676 |
| 85 | Abnormal large intestine physiology (HP:0012700) | 2.16816065 |
| 86 | Exercise intolerance (HP:0003546) | 2.15934941 |
| 87 | Breast hypoplasia (HP:0003187) | 2.15829557 |
| 88 | Hypoparathyroidism (HP:0000829) | 2.15372317 |
| 89 | Reticulocytosis (HP:0001923) | 2.14488988 |
| 90 | Cerebral edema (HP:0002181) | 2.14130382 |
| 91 | Chronic obstructive pulmonary disease (HP:0006510) | 2.13490944 |
| 92 | Obstructive lung disease (HP:0006536) | 2.13490944 |
| 93 | Vacuolated lymphocytes (HP:0001922) | 2.12428131 |
| 94 | Type 2 muscle fiber atrophy (HP:0003554) | 2.09428024 |
| 95 | Nasal polyposis (HP:0100582) | 2.08663375 |
| 96 | Abnormality of T cells (HP:0002843) | 2.07960190 |
| 97 | Muscle fiber atrophy (HP:0100295) | 2.07345008 |
| 98 | Abnormality of glycolipid metabolism (HP:0010969) | 2.06908336 |
| 99 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.06908336 |
| 100 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.06908336 |
| 101 | Bowel incontinence (HP:0002607) | 2.04256467 |
| 102 | Abnormality of glycolysis (HP:0004366) | 2.03733272 |
| 103 | Increased serum pyruvate (HP:0003542) | 2.03733272 |
| 104 | Self-mutilation (HP:0000742) | 2.01499475 |
| 105 | Increased serum ferritin (HP:0003281) | 2.00996181 |
| 106 | Abnormal gallbladder morphology (HP:0012437) | 1.99980573 |
| 107 | Vaginal fistula (HP:0004320) | 1.99870159 |
| 108 | Selective tooth agenesis (HP:0001592) | 1.98605226 |
| 109 | Severe visual impairment (HP:0001141) | 1.97284052 |
| 110 | Progressive macrocephaly (HP:0004481) | 1.96941642 |
| 111 | Respiratory failure (HP:0002878) | 1.96870273 |
| 112 | Respiratory difficulties (HP:0002880) | 1.95459923 |
| 113 | Abnormality of the gallbladder (HP:0005264) | 1.95031727 |
| 114 | Oral leukoplakia (HP:0002745) | 1.93237435 |
| 115 | Beaking of vertebral bodies (HP:0004568) | 1.92487295 |
| 116 | Premature ovarian failure (HP:0008209) | 1.90526161 |
| 117 | Rough bone trabeculation (HP:0100670) | 1.90430532 |
| 118 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.89552570 |
| 119 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.88052047 |
| 120 | Methylmalonic aciduria (HP:0012120) | 1.86943081 |
| 121 | Eczematoid dermatitis (HP:0000976) | 1.86067054 |
| 122 | Hypergonadotropic hypogonadism (HP:0000815) | 1.85911893 |
| 123 | Pulmonary fibrosis (HP:0002206) | 1.85910278 |
| 124 | Septate vagina (HP:0001153) | 1.85557652 |
| 125 | Delusions (HP:0000746) | 1.84328848 |
| 126 | Rhabdomyolysis (HP:0003201) | 1.83744231 |
| 127 | Abnormality of B cell number (HP:0010975) | 1.83736912 |
| 128 | B lymphocytopenia (HP:0010976) | 1.83736912 |
| 129 | Epistaxis (HP:0000421) | 1.82715773 |
| 130 | Spastic paraparesis (HP:0002313) | 1.80749345 |
| 131 | Congenital malformation of the right heart (HP:0011723) | 1.79999211 |
| 132 | Double outlet right ventricle (HP:0001719) | 1.79999211 |
| 133 | Recurrent skin infections (HP:0001581) | 1.79715029 |
| 134 | Entropion (HP:0000621) | 1.79462115 |
| 135 | Abnormality of the nasal mucosa (HP:0000433) | 1.79177667 |
| 136 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.77959973 |
| 137 | Rectovaginal fistula (HP:0000143) | 1.77955931 |
| 138 | Rectal fistula (HP:0100590) | 1.77955931 |
| 139 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.77604639 |
| 140 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.77362820 |
| 141 | Agnosia (HP:0010524) | 1.77132074 |
| 142 | Orchitis (HP:0100796) | 1.77027700 |
| 143 | Prolonged neonatal jaundice (HP:0006579) | 1.76963425 |
| 144 | Premature graying of hair (HP:0002216) | 1.76377895 |
| 145 | Cutaneous melanoma (HP:0012056) | 1.76351790 |
| 146 | IgG deficiency (HP:0004315) | 1.75168456 |
| 147 | Nonimmune hydrops fetalis (HP:0001790) | 1.75011813 |
| 148 | Emotional lability (HP:0000712) | 1.74040210 |
| 149 | Abnormal spermatogenesis (HP:0008669) | 1.73636454 |
| 150 | Megaloblastic anemia (HP:0001889) | 1.73571662 |
| 151 | Meningitis (HP:0001287) | 1.72440743 |
| 152 | Progressive microcephaly (HP:0000253) | 1.72355574 |
| 153 | Lymphoma (HP:0002665) | 1.71811463 |
| 154 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.71510254 |
| 155 | Agammaglobulinemia (HP:0004432) | 1.71336852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIM2 | 4.39148181 |
| 2 | NME2 | 4.34190436 |
| 3 | ARAF | 3.42484293 |
| 4 | STK16 | 3.38051802 |
| 5 | EIF2AK1 | 2.91754882 |
| 6 | BUB1 | 2.69598620 |
| 7 | SMG1 | 2.53794406 |
| 8 | VRK2 | 2.47417517 |
| 9 | TESK2 | 2.46549979 |
| 10 | BRAF | 2.40949427 |
| 11 | MAP4K1 | 2.39149926 |
| 12 | TESK1 | 2.13487238 |
| 13 | WEE1 | 2.00088874 |
| 14 | EIF2AK3 | 1.91086002 |
| 15 | BCKDK | 1.89393292 |
| 16 | TLK1 | 1.77236671 |
| 17 | ERN1 | 1.68498652 |
| 18 | PIK3CG | 1.68195786 |
| 19 | FLT3 | 1.67971324 |
| 20 | KIT | 1.65481154 |
| 21 | IRAK4 | 1.65448902 |
| 22 | TBK1 | 1.51214172 |
| 23 | ACVR1B | 1.50791568 |
| 24 | VRK1 | 1.46903697 |
| 25 | CCNB1 | 1.42414250 |
| 26 | MAPK11 | 1.42337938 |
| 27 | PDK2 | 1.40709263 |
| 28 | CDK19 | 1.39731446 |
| 29 | KDR | 1.39716866 |
| 30 | ZAP70 | 1.33281873 |
| 31 | BTK | 1.28793725 |
| 32 | PIM1 | 1.25846721 |
| 33 | BLK | 1.23391676 |
| 34 | ICK | 1.20520907 |
| 35 | ZAK | 1.20000607 |
| 36 | PBK | 1.18332544 |
| 37 | NME1 | 1.15261433 |
| 38 | DYRK3 | 1.14528126 |
| 39 | CDK8 | 1.14257077 |
| 40 | TAOK2 | 1.13725436 |
| 41 | ILK | 1.12555903 |
| 42 | RAF1 | 1.09587592 |
| 43 | MAP3K11 | 1.07930036 |
| 44 | JAK3 | 1.07614488 |
| 45 | IKBKB | 1.06799825 |
| 46 | PRPF4B | 1.04508173 |
| 47 | CLK1 | 1.03792917 |
| 48 | ABL2 | 1.02776914 |
| 49 | TYK2 | 1.02584121 |
| 50 | IRAK2 | 1.01689166 |
| 51 | CDC7 | 1.00757541 |
| 52 | SCYL2 | 1.00619256 |
| 53 | CSF1R | 0.98263007 |
| 54 | SYK | 0.98098676 |
| 55 | CHEK2 | 0.97842947 |
| 56 | RPS6KA4 | 0.96293206 |
| 57 | TXK | 0.95712428 |
| 58 | PLK4 | 0.93796652 |
| 59 | PRKD3 | 0.93346467 |
| 60 | IKBKE | 0.91345251 |
| 61 | IRAK3 | 0.90715291 |
| 62 | BRSK2 | 0.90558922 |
| 63 | NEK2 | 0.89044434 |
| 64 | LRRK2 | 0.88178230 |
| 65 | MAP3K14 | 0.83716091 |
| 66 | TSSK6 | 0.83657207 |
| 67 | SRPK1 | 0.83121677 |
| 68 | MAPKAPK3 | 0.82556285 |
| 69 | TEC | 0.80324420 |
| 70 | PAK1 | 0.80167070 |
| 71 | TRIB3 | 0.78920435 |
| 72 | MAPK12 | 0.77274040 |
| 73 | NEK9 | 0.77040559 |
| 74 | SIK1 | 0.76376340 |
| 75 | PLK1 | 0.75756172 |
| 76 | MAP3K3 | 0.74886181 |
| 77 | CDK12 | 0.73112250 |
| 78 | MAP3K1 | 0.72110751 |
| 79 | TTK | 0.71412398 |
| 80 | CDK7 | 0.71358365 |
| 81 | PASK | 0.70923058 |
| 82 | AURKA | 0.70597797 |
| 83 | LIMK1 | 0.69876491 |
| 84 | NEK1 | 0.67025397 |
| 85 | CHEK1 | 0.66206494 |
| 86 | KSR2 | 0.65939056 |
| 87 | DAPK3 | 0.65430961 |
| 88 | GRK6 | 0.62459971 |
| 89 | PAK4 | 0.62247634 |
| 90 | CSNK1G3 | 0.60510999 |
| 91 | TAOK1 | 0.60341960 |
| 92 | STK10 | 0.59401656 |
| 93 | MOS | 0.58238171 |
| 94 | TAOK3 | 0.57180931 |
| 95 | AKT2 | 0.56446671 |
| 96 | RPS6KA5 | 0.55750732 |
| 97 | AURKB | 0.55121559 |
| 98 | ATR | 0.55036896 |
| 99 | SIK2 | 0.54754387 |
| 100 | MAP3K8 | 0.54578622 |
| 101 | MAP3K10 | 0.54055933 |
| 102 | LYN | 0.53497935 |
| 103 | MAP2K3 | 0.52325603 |
| 104 | PDPK1 | 0.52045225 |
| 105 | RPS6KA6 | 0.50571806 |
| 106 | EEF2K | 0.50227434 |
| 107 | MAPKAPK5 | 0.49762973 |
| 108 | STK4 | 0.49577253 |
| 109 | PRKD2 | 0.48982010 |
| 110 | MUSK | 0.48624336 |
| 111 | CAMK2G | 0.47991327 |
| 112 | LCK | 0.47575817 |
| 113 | BRSK1 | 0.47319724 |
| 114 | CSNK2A1 | 0.46624692 |
| 115 | CDK4 | 0.45992637 |
| 116 | MAPK15 | 0.44756032 |
| 117 | CDK11A | 0.43462524 |
| 118 | MAPKAPK2 | 0.43084276 |
| 119 | DAPK1 | 0.42448433 |
| 120 | CDK2 | 0.41682888 |
| 121 | MATK | 0.41662051 |
| 122 | TGFBR1 | 0.41020896 |
| 123 | BMX | 0.40812768 |
| 124 | CSNK2A2 | 0.39550637 |
| 125 | ADRBK2 | 0.39416478 |
| 126 | CDK9 | 0.39299829 |
| 127 | RPS6KB2 | 0.39130187 |
| 128 | MTOR | 0.39073274 |
| 129 | BMPR2 | 0.38989063 |
| 130 | CDK14 | 0.38040328 |
| 131 | RIPK4 | 0.37891487 |
| 132 | RPS6KC1 | 0.37407677 |
| 133 | RPS6KL1 | 0.37407677 |
| 134 | STK24 | 0.37266283 |
| 135 | SIK3 | 0.37187735 |
| 136 | PRKCD | 0.37103848 |
| 137 | MAP2K2 | 0.37011563 |
| 138 | PRKCI | 0.36947667 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.16500951 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.04828350 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 4.03329291 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.21030433 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.84371094 |
| 6 | Protein export_Homo sapiens_hsa03060 | 2.72400631 |
| 7 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.64186854 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.62345895 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.31601491 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.27758743 |
| 11 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.16508077 |
| 12 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.11315698 |
| 13 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.04448992 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.96577822 |
| 15 | Sulfur relay system_Homo sapiens_hsa04122 | 1.96163032 |
| 16 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.94364847 |
| 17 | Spliceosome_Homo sapiens_hsa03040 | 1.86039884 |
| 18 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.74945849 |
| 19 | Parkinsons disease_Homo sapiens_hsa05012 | 1.71705204 |
| 20 | Basal transcription factors_Homo sapiens_hsa03022 | 1.66960661 |
| 21 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.63678129 |
| 22 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.53207731 |
| 23 | RNA transport_Homo sapiens_hsa03013 | 1.44710620 |
| 24 | Cell cycle_Homo sapiens_hsa04110 | 1.44430395 |
| 25 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.42412446 |
| 26 | Purine metabolism_Homo sapiens_hsa00230 | 1.40861208 |
| 27 | Huntingtons disease_Homo sapiens_hsa05016 | 1.39178501 |
| 28 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.18762073 |
| 29 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.17579758 |
| 30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.16926617 |
| 31 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.12011739 |
| 32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.09943983 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.09417800 |
| 34 | RNA degradation_Homo sapiens_hsa03018 | 1.09336399 |
| 35 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.05790770 |
| 36 | Legionellosis_Homo sapiens_hsa05134 | 1.04109281 |
| 37 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.00605674 |
| 38 | Other glycan degradation_Homo sapiens_hsa00511 | 0.99160463 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.98921014 |
| 40 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.98474512 |
| 41 | Alzheimers disease_Homo sapiens_hsa05010 | 0.98069792 |
| 42 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.96762065 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.96548327 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.95862171 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.93854366 |
| 46 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.91422607 |
| 47 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.90017086 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.87949420 |
| 49 | Allograft rejection_Homo sapiens_hsa05330 | 0.87316607 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.85280009 |
| 51 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.85186484 |
| 52 | Leishmaniasis_Homo sapiens_hsa05140 | 0.82414900 |
| 53 | Measles_Homo sapiens_hsa05162 | 0.81919323 |
| 54 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.81684794 |
| 55 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.80613520 |
| 56 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.78746141 |
| 57 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.78377053 |
| 58 | Shigellosis_Homo sapiens_hsa05131 | 0.77839040 |
| 59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.75956380 |
| 60 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.75604630 |
| 61 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.75529388 |
| 62 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.74620811 |
| 63 | Bladder cancer_Homo sapiens_hsa05219 | 0.73816448 |
| 64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.71749865 |
| 65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.71188815 |
| 66 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69363982 |
| 67 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.66351216 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.65134424 |
| 69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64571952 |
| 70 | Carbon metabolism_Homo sapiens_hsa01200 | 0.62462887 |
| 71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.60994242 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.60054374 |
| 73 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.59481594 |
| 74 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59187432 |
| 75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58791169 |
| 76 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.57903593 |
| 77 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56267469 |
| 78 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.54282768 |
| 79 | Asthma_Homo sapiens_hsa05310 | 0.52432978 |
| 80 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.52386905 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51184303 |
| 82 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.49062406 |
| 83 | Malaria_Homo sapiens_hsa05144 | 0.48936106 |
| 84 | Lysosome_Homo sapiens_hsa04142 | 0.48711634 |
| 85 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.47068457 |
| 86 | Pertussis_Homo sapiens_hsa05133 | 0.46422364 |
| 87 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.45567016 |
| 88 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45505093 |
| 89 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.45295486 |
| 90 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.44794507 |
| 91 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.44787170 |
| 92 | Alcoholism_Homo sapiens_hsa05034 | 0.43339669 |
| 93 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.43282123 |
| 94 | Peroxisome_Homo sapiens_hsa04146 | 0.43229924 |
| 95 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.42231545 |
| 96 | Hepatitis B_Homo sapiens_hsa05161 | 0.41873609 |
| 97 | Influenza A_Homo sapiens_hsa05164 | 0.41858012 |
| 98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.41431956 |
| 99 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.40956133 |
| 100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40866604 |
| 101 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40400602 |
| 102 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40371249 |
| 103 | Phagosome_Homo sapiens_hsa04145 | 0.39846954 |
| 104 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.39595039 |
| 105 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.39408085 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39112670 |
| 107 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.38585519 |
| 108 | Tuberculosis_Homo sapiens_hsa05152 | 0.38265356 |
| 109 | Thyroid cancer_Homo sapiens_hsa05216 | 0.37939183 |
| 110 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.36842979 |
| 111 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.35495831 |
| 112 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.35253781 |
| 113 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.35031615 |
| 114 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.34993450 |
| 115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.34127032 |
| 116 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.33967531 |
| 117 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.33462635 |
| 118 | Salmonella infection_Homo sapiens_hsa05132 | 0.30993253 |
| 119 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.27676326 |
| 120 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.27135707 |
| 121 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.26594861 |
| 122 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.26355310 |
| 123 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.25980327 |
| 124 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.23485092 |
| 125 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.23345901 |
| 126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19311062 |
| 127 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.18613459 |

